Menstrual phase-dependent gene expression differences in periurethral vaginal tissue from women with stress incontinence

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 89-97

  Chen, Bertha ^a   Wen, Yan ^a   Zhang, Zhaomei ^b   Wang, Hongbo ^a   Warrington, Janet A ^b   Polan, Mary Lake ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Thermo Fisher Scientific   (United States)

Author keywords

Extracellular matrix remodeling; Gene expression; Incontinence; Microarray; Stress urinary

Indexed keywords

COLLAGEN FIBER; COLLAGEN TYPE 6; COMPLEMENTARY RNA; ESTROGEN RECEPTOR ALPHA; INTERLEUKIN 1 RECEPTOR; LAMININ; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN SERINE THREONINE KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; BLADDER NECK; CLUSTER ANALYSIS; COLLAGEN METABOLISM; EXTRACELLULAR MATRIX; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MENSTRUATION; NUCLEOTIDE SEQUENCE; PELVIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANK SUM TEST; STRESS INCONTINENCE; STUDENT T TEST; UNINDEXED SEQUENCE; URETHRA; UROGENITAL SYSTEM; VAGINA;

EID: 0037660810     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.373     Document Type: Article

References (33)

1. Yarnell JW, Voyle GJ, Richards CJ, Stephenson TP. The prevalence and severity of urinary incontinence in women. J Epidemiol Community Health 1981;35:71-4.
2. Iosif CS, Bekassy Z, Rydhstrom H. Prevalence of urinary incontinence in middle-aged women. Int J Gynaecol Obstet 1988;26:255-9.
3. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. BMJ 1980;281:1243-5.
4. Feneley CL, Shepherd AM, Powell PH, Blannin J. Urinary incontinence: prevalence and needs. Br J Urol 1979;51:493-6.
5. Benassi L, Bocchialini E, Bertelli M, Kaihura CT, Ricci L, Siliprandi V. Risk of genital prolapse and urinary incontinence due to pregnancy and delivery: a prospective study. Minerva Ginecol 2002;54:317-24.
6. Peyrat L, Haillot O, Bruyere F, Bontin JM, Bertrand P, Lanson Y. Prevalence and risk factors of urinary incontinence in young and middle-aged women. BJU Int 2002;89:61-6.
7. Graham CA, Mallett VT. Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2001;185:116-20.
8. Buchsbaum GM, Chin M, Glantz C, Guzick D. Prevalence of urinary incontinence and associated risk factors in a cohort of nuns. Obstet Gynecol 2002;100:226-9.
9. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 1996;24:197-204.
10. Rechberger T, Postawski K, Jakowicki JA, Gunja-Smith Z, Woessner JF Jr. Role of fascial collagen in stress urinary incontinence. Am J Obstet Gynecol 1998;179:1511-4.
11. Keane DP, Sims TJ, Abrams P, Bailey AJ. Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol 1997;104:994-8.
12. Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2002;13:80-7.
13. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-80.
14. Mahadevappa M, Warrington JA. A high-density probe array sample preparation method using 10- to 100-fold fewer cells. Nat Biotechnol 1999;17:1134-6.
15. Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M. Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol Genomics 2000;2:143-7.
16. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL. Multiplexed biochemical assays with biological chips. Nature 1993;364:555-6.
17. Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 2001;83:177-85.
18. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
19. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 1999;96:2907-12.
20. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-7.
21. Eyre DR. The specificity of collagen cross-links as markers of bone and connective tissue degradation. Acta Orthop Scand Suppl 1995;266:166-70.
22. Nimni ME. Collagen: structure, function, and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum 1983;13:1-86.
23. Bergman A, Elia G, Cheung D, Perelman N, Nimni ME. Biochemical composition of collagen in continent and stress urinary incontinent women. Gynecol Obstet Invest 1994;37:48-51.
24. Rechberger T, Donica H, Baranowski W, Jakowicki J. Female urinary stress incontinence in terms of connective tissue biochemistry. Eur J Obstet Gynecol Reprod Biol 1993;49:187-91.
25. Ulmsten U, Ekman G, Giertz G, Malmstrom A. Different biochemical composition of connective tissue in continent and stress incontinent women. Acta Obstet Gynecol Scand 1987;66:455-7.
26. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996;347:1658-61.
27. Kuscu NK, Lacin S, Vatansever S, Yildirim Y, Var A, Uyanik BS, et al. Immunolocalization of transforming growth factor-beta 3 in pregnant human myometrium. Acta Obstet Gynecol Scand 2001;80:1079-83.
28. Lee BS, Nowak RA. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab 2001;86:913-20.
29. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, et al. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem 2002;277:35532-40.
30. Roberts M, Dickson G. The future of Duchenne muscular dystrophy gene therapy: shrinking the dystrophin gene. Curr Opin Mol Ther 2002;4:343-8.
31. Amin AR. Type II interleukin-1beta receptor: a candidate for gene therapy in human arthritis. Clin Orthop 2000;379 (Suppl):S179-88.
32. Seidel B, Keilhoff G, Reinheckel T. Wolf G. Differentially expressed genes in hippocampal cell cultures in response to an excitotoxic insult by quinolinic acid. Brain Res Mol Brain Res 1998;60:296-300.
33. Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, et al. Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem 2002;12:47-54.